NCT03389321 - Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 9, 2018

Primary Completion Date

February 6, 2018

Study Completion Date

February 6, 2018

Conditions

Healthy Subjects

Interventions

DRUG

Riociguat (Adempas)

Riociguat film-coated tablets for oral administration at a strength of 1 mg

DRUG

Macitentan (Opsumit)

Macitentan film-coated tablets for oral administration at a strength of 10 mg

Trial Locations (1)

CRS Clinical Research Services Mannheim, Mannheim